Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

2nd International Conference on Drug Discovery 2026

The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis Conferences, aims to bring together researchers, scientists, industry leaders, and academicians from around the world to explore groundbreaking innovations in drug...

NextGen Pharma 2026

NextGen Pharma, a premier global forum dedicated to exploring the latest innovations, emerging technologies, and future-focused strategies in the pharmaceutical industry. NextGen Pharma, a premier global forum dedicated to exploring the latest...

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

BD a leading global medical technology company, announced positive nine-month results from the iliac cohort of the AGILITY Investigational Device Exemption trial evaluating the Revello™ Vascular Covered Stent. Presented at VIVA 2026 by Sean Lyden,...

The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

Nordic Pharma, Inc., a subsidiary of SEVER Life Sciences B.V., will be held at the annual meeting of the American Academy of Ophthalmology from 9 to 12. October in New Orleans, Louisiana, introduce the LACRIFILL ® Canalicular Gel – a novel therapy...

Arkayli Biopharma Inc. Receives FDA Study May Proceed Response to IND and NIH SBIR Grant to Advance Clinical Development of ARK001 for a Rare Pediatric Disease

Arkayli BioPharma Inc. a biopharmaceutical company dedicated to developing innovative therapies for rare dermatologic conditions, announced that the U.S. Food and Drug Administration (FDA) has responded to its Investigational New Drug (IND)...

Carterra Advances Drug Discovery Through New Lab-In-The-Loop Scientific Collaboration

Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing...

MedaSystems Announces Major Platform Update to Help Life Sciences Organizations Govern and Scale Expanded Access Programs

MedaSystems, a SaaS platform for managing Expanded Access, Post-Trial Access and Investigator-Initiated Study programs, announced the release of MedaSystems Version 3.3, one of the company’s most significant platform updates to date. The release...

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

Dr. Oregonin Inc. announced that it has completed U.S. Food and Drug Administration (FDA) registration for OLTIS DENTAL-X, paving the way for its official commercial entry into the North American oral-care market. The product's authorization...

SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

A larger rebate does not guarantee lower pharmacy spending, warns Paul Pruitt, Chief Growth Officer and Co-Founder of SHARx, a procurement management solution for high-cost prescription drugs. Demand for GLP-1 medications, specialty drugs and...

Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, announced the launch of Premia™ Precision, a new quality standard for elastomer components, designed to support sensitive and high-value injectable...

Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

Hovione, a globally integrated pharmaceutical contract development and manufacturing organization (CDMO), announced it will commission the world's first ConsiGma® CDC Flex – a next generation continuous tableting line – at its East Windsor, New...

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

CaseBioscience® announced its participation in a multidisciplinary team led by Likarda that has been awarded up to $7.3 million by the Advanced Research Projects Agency for Health (ARPA-H) through its BioStabilization Systems (BoSS) program. Led...

Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.

Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish specialists to address the complexity of...

Niagen Bioscience Puts 25 Years of NAD+ Science Behind “Don’t Get Old. Age Better.®” — a New Campaign for Its Niagen® Brand Featuring Legendary Surfer Kelly Slater

Niagen Bioscience, Inc. the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of “Don't Get Old. Age Better.®,” a new brand campaign for its Niagen® (patented...

Upsher-Smith Launched Fluvoxamine Maleate Extended-Release Capsules

Upsher-Smith Laboratories, LLC a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), today announced the recent launch of Fluvoxamine Maleate Extended-Release Capsules in 100 mg and 150 mg strengths. According to IQVIA, the...

Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs

Cronus Pharma LLC, a fully integrated animal health company, announced the launch of Florfinasone Otic (florfenicol, terbinafine, mometasone furoate), an FDA-approved product indicated for the treatment of otitis externa in dogs associated with...

Risk & Compliance Pharma & Life Sciences Conference 2026

The 4th Annual Risk & Compliance Pharma & Life Sciences Conference takes place on October 1, 2026, at One America Square in London, UK. The 4th Annual Risk & Compliance Pharma & Life Sciences Conference takes place on October 1, 2026, at One...

Packaging Compliance Labs enters pharmaceutical testing market with dedicated lab and expert leadership

Packaging Compliance Labs (PCL) is making a significant move into the pharmaceutical testing market by investing in a dedicated cGMP pharma lab and state-of-the-art capital equipment. "Through industry surveys and direct engagement with CDMOs and...

Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill

o, the leading direct-to-patient healthcare company, announced a research collaboration with Novo that will generate first-of-its-kind real-world evidence on the Wegovy® pill. The debut research from the collaboration, presented on September 30 at...

Cresilon launched next-generation TRAUMAGEL.

Cresilon Inc. a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced the launch of TRAUMAGEL®'s next generation, which officially debuts at EMS World Expo 2026 in Orlando, Florida. This next generation...